Transition to Rebif New Formulation

Clinical trial NCT00619307 · COMPLETED

Trial details

NCT number: NCT00619307
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2007-07-01
Primary completion: 2008-04-01
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.